Sperm viability in human semen specimens cryostored
at 5°C using the Bio-Tranz container
system for
semen transport
(From Middle East Fertility Society Journal, Vol. 3, No.
3, 1998)
Panayiotis M. Zavos
Juan R. Correa
William Clark
Panayota N. Zarmakoupis-Zavos
ABSTRACT
- Objective: To asses a protocol designed for transport of
unprocessed human semen specimens from the production site to distant laboratories.
- Design: The viability of semen specimens stored from
the time of collection to the time at which the specimens were to be
processed and used (24 hr after collection) was evaluated using the Bio-Tranz™
technology. Specimens were assessed for percentage and grade of motility,
and for the sperm membrane functional integrity as measured by the hypoosmotic
swelling (HOS) test. The semen specimen was split into two aliquots (Aliquot
1 and 2) and transferred to 15.0 mL conical centrifuge tubes. Aliquot-1
was
used without further processing and Aliquot 2 was mixed 1:1 (v/v) with
TYB media. Aliquot 1 was maintained at 21°C. Aliquot 2 slowly cooled to
5°C by placing the tube into the middle compartment of the Bio-Tranz™ container.
- Setting: Andrology Institute of Lexington, Lexington,
Kentucky.
- Patients: Semen specimens (n=30) were collected by
each participant at intercourse via the use of the MFP TM and delivered
to the Andrology Institute of Lexington for processing.
- Main Outcome Measure(s): Viable cryostorage of semen
specimens during transport at 5°C for 24 hr for andrological evaluation
or use in assisted reproductive technologies.
- Result(s): Significant differences (P<0.05) in all
sperm parameters assessed were noticed between the unprocessed and TYB-prepared
specimens after storage for 24 hr. Sperm characteristics were improved
when preparing the specimens using TYB (Time 0; P<0.05). Sperm characteristics
between the unprocessed (Time 0) and TYB-prepared specimens (24 hr) were
not different (P>0.05).
- Conclusion(s): Collection and preparation of human semen
for transport at SoC is possible and that the Bio-Tranz ™ container maintains
adequate sperm viability after 24 hours of cryostorage. The use of the
Bio-Tranz™ container is convenient for patients that request semen processing
services or for other clinical purposes at distant locations.
- Key words: semen, spermatozoa, cryostorage, viability,
transport
Transport of unprocessed human semen specimens from the production site to
distant laboratories for
andrological evaluation and other clinical uses requires the development
of proper protocols and devices for the maintenance of sperm viability
and fertilizability during and after transport 1. Spermatozoa recovered
following storage at 5°C in TEST-Yolk buffer (TYB), show enhanced survivability
and fertilizing capacity than spermatozoa frozen at subzero (-196°C) temperatures
following short-term incubation between 24 and 96 hr (1-7). It has also
been documented that, the treatment of human spermatozoa with TYB can enhance
their ability to penetrate zona-free hamster oocytes (ZFHO) and bind to
the zona pellucida as measured by the sperm penetration assay (SPA) or
hemizona (HZA) assays (1, 5, 8-11). Preincubation of spermatozoa in TYB
have been shown to increase the percentage of human oocytes fertilized
via in vitro fertilization via in vitro fertilization (IVF) procedures
(1, 5, 11, 12). It seems that a higher proportion of the sperm population
undergo capacitation during TYB incubation, which results in synchronization
of the acrosome reaction following sperm washing and preparation for use
in the various assisted reproductive technologies (5, 6, 11). Subsequently,
the increased percentage of acrosome-reacted spermatozoa that is seen after
incubation in TYB may indicate that a larger percentage of the sperm population
acquired the ability to penetrate the ovum and account for the higher rates
of fertilization observed (1, 5, 6, 11).
The Bio-Tranz™ container, which was designed to cool and maintain semen specimens
at 5°C during transport, consists of a properly insulated Polystyrene container,
TYB, a nonspermicidal condom-shaped semen collection device and test tubes.
The viability of semen specimens stored from the time of collection to the
time at which the specimens were to be processed and used (24 hr after collection),
was assessed using the Bio-Tranz" technology.
MATERIALS AND METHODS
Semen Collection and Assessment
Thirty normozoospermic (World Health Organization standards) (13); donors
participated in this study. Each donor produced a semen specimen after 3 to
4 days of abstinence via intercourse using a semen collection device provided
with the Bio-Tranz™ (14, 15). The Bio-Tranz™ technology (ZDL, Inc., Lexington,
KY, USA) consists of a Polystyrene (Styrofoam) container which contains a
cold pak, TYB, the Hygiene™ seminal collection kit, and a Styrofoam separator
that divides the Bio-Tranz™ container into two compartments (Fig. 1). The
Hygiene™ semen collection kit consists of a nonspermicidal condom-shaped collection
device (Male Factor Pak™), funnel and two 15.0 mL conical centrifuge tubes.
Semen specimens were assessed for percentage and grade of motility, and for
the sperm membrane functional status as measured by the hypoosmotic swelling
(HOS) test (16). Grade of motility was measured using a scale of 0 to 4 to
describe the progressive motility as described by Zavos et a1. (17).
Experimental Design
Semen specimens were split into two aliquots (Aliquot 1 and 2) and transferred
to 15.0 mL conical centrifuge tubes following initial assessment. Aliquot
1 was used as control without further processing and Aliquot 2 was mixed 1:1
(v/v) with TYB media. Aliquot 1 was maintained at 21°C (ambient room temperature).
Aliquot 2 was slowly cooled to 5°C (approximately 0.1°C/min) by placing the
tube containing the diluted seminal specimen into the middle compartment of
the Bio-Tranz™ container. A separator cover (thin piece of Styrofoam with
two holes) was placed over the test tube. The specimen preparation procedure
was completed by placing a frozen cold pak on top of the separator and then
closing the Bio-Tranz™ container prior to transport. The semen-TYB mixture
was cooled via conduction as it was placed closed to the frozen cold pak (-20°c).
The low temperature of the frozen cold pak coupled with distance of the semen-TYB
mixture in reference to frozen cold pak allowed the rate of cooling of the
semen-TYB mixture (approximately 0.1°C/min). Semen specimens (Aliquot 1 and
2) were assessed after 24 hr of storage as previously described.
Semen Re-Warming
The semen-TYB mixture was removed from the Bio-Tranz™ container and placed
in water bath (37°C) for 15-20 minutes as previously described (2, 3). The
semen-TYB mixture was gently agitated periodically during the incubation period
in order to keep the re-warmed spermatozoa in suspension.
Table 1: Sperm viability of Semen specimens diluted and cyrostored in
TEST-yolk buffer (TYB) at 5C during 24 hours of cyrostorage
| |
Sperm characteristics assessed |
| Semen Treatments |
Motility (%) |
Grade (0 to 4) |
HOS * (%) |
| Fresh, 0 hours |
55.0 ± 7.5 |
3.4 ± 0.3 |
64.0 ± 11.0 |
| Fresh, 24 hours |
17.7 ± 6.1 |
1.6 ± 0.5 |
23.0 ± 11.6 |
| TYB, 0 hours |
61.8 ± 7.6 |
3.5 ± 0.2 |
68.7 ± 10.8 |
| TYB, 24 hours |
52.8 ± 9.0 |
3.3 ± 0.2 |
58.7 ± 11.4 |
Statistics
The results were reported as means±SD. The data was analyzed by ANOVA procedures
using the SAS Statistical Package (18). A level of P<0.05 was considered
statistically significant. The statistical model included the effects of patients,
temperature and sperm characteristics assessed.
RESULTS
The results obtained are summarized in Table 1. Significant differences (P<0.05)
in all sperm parameters assessed were noticed between the unprocessed and
TYB-prepared specimens after storage for 24 hr. Sperm characteristics were
also improved when preparing the specimens using TYB after collection (Time
0; P<0.05). Sperm characteristics between the unprocessed (Time 0) and
TYB-prepared specimens (24 hr) were not significantly different (P>0.05).
The percentage and grade of motility, as well as, the integrity of the sperm
membrane declined by 68, 53 and 65% after 24 hr in specimens stored at 21°C,
respectively. Similarly, in specimens stored at 5°C using TYB, those sperm
characteristics declined by 15, 6 and 15% after 24 hr of cryostorage.
DISCUSSION
The use of cryopreserved semen for artificial insemination using donor semen
(AID) is steadily increasing, although the cryopreservation (-196°C) techniques
presently employed reduce significantly the fertilization potential of human
spermatozoa (19). Spermatozoa cryostored at 5°C in TYB show improved survivability
than spermatozoa frozen at subzero temperatures (2, 15). The use of cryopreserved
spermatozoa provides the advantage of arranging patients and performance of
assisted reproductive techniques (ART) such as intrauterine insemination (lUI),
IVF, intra cytoplasmic sperm injection (ICSI) and others (3, 20, 21). A newly
established technique has been introduced to optimize fertility rates and
to decrease the difficulty in aligning patients or making semen available
from patients that either travel on the day that the procedure is to be performed
or they happen to be residing at another distant location from where the procedures
are performed. This technique consists of collecting, diluting and cryostoring
(5°C) human spermatozoa diluted with TYB for approximately 24 to 48 hr and
up to 96 hr (3, 6, 7). The fertilization potential of spermatozoa incubated
and cryostored in TYB can also be enhanced by selection of spermatozoa via
various sperm preparation techniques employed in ART after the cryostorage
period (3, 17, 22-24). It has also been documented that the treatment of human
spermatozoa with TYB can enhance their ability to penetrate ZFHO (1). Preincubation
of spermatozoa in TYB have been shown to increase the percentage of human
oocytes fertilized via IVF procedures (12). It seems that following sperm
incubation in TYB at 5°C, more spermatozoa undergo capacitation and synchronization
of the acrosome reaction (5, 6). Subsequently, the increased proportion of
capacitated spermatozoa that is noted after TYB incubation may indicate that
a higher percentage of spermatozoa achieve the acrosome reaction stage and
consequently the ability to penetrate the ovum, which could account for the
higher fertilization rates observed (1,5,6,8-11). Most recently, it was also
shown that incubation of spermatozoa in TYB followed by filtration using the
Sperm Prep™ Sephadex filtration method can improve the recovery of antisperm
antibody (ASA)-free spermatozoa by selectively masking and entrapping spermatozoa
with ASA bound to its surface (25).
The development of methods for the transport of semen specimens processed
and cryostored in TYB combines the advantages of maintaining sperm viability,
and possibly the sperm fertilizing ability, while in transit. Following delivery
to the andrological or ART laboratory, the specimens are then processed for
clinical evaluation or used for various forms of ART including lUI. The employment
of this technology also allows the performance of various inseminations obtained
from the cryopreserved specimen, without the patient having to produce multiple
specimens within a short period of time (24 to 96 hr). The results obtained
in the current study show that the collection and preparation of human semen
for transport at 5°C is possible and that the Bio-Tranz™ container maintains
adequate sperm viability after 24 hr of cryostorage. The use of the Bio-Tranz™
container is convenient for patients from distant locations that request semen
processing services or for other clinical purposes such as semen cryopreservation,
evaluation and processing for use in the various forms of ART and also lUI
procedures. The Bio-Tranz" is a rather unique product and will revolutionize
the way liquid (non-frozen) semen is shipped and utilized for patients that
require various clinical and laboratory procedures performed on their semen
and they happen to be located at distant locations from the site where those
procedures are performed.
REFERENCES
- Bolanos JR, Overstreet JW, Katz DF. Human sperm penetration of zona-free
hamster eggs after storage of the semen for 48 hours at 2°C to 5°C. Fertil
Steril 1983;39:536-41.
- Zavos PM, Goodpasture JC, Zaneveld LJD, Cohen MR. Motility and enzyme
activity of human spermatozoa stored. for 24 hours at +5°C and -196°C.
Fertil Steril 1980; 34:607-9.
- Zavos PM, Correa JR, Sofikitis N, Kofinas GD, Zarmakoupis PN. A method
of short-term cryostorage and selection of viable sperm for use in the
various assisted reproductive techniques.
Tohoku J Exp Moo 1995; 176: 75-81.
- Jaskey DG and Cohen MR. Twenty-four to ninety-six-hour storage of human
spermatozoa in test-yolk buffer. Fertil
Steril 1981; 35: 205-8.
- Falk RM, Silverberg KM, Fetterolf PM, Kirchner FK,
Rogers BJ. Establishment of TEST-yolk buffer enhanced
sperm penetration assay limits for fertile males. Fertil Steril
1990; 54: 121-6.
- Kofinas GD, Zavos PM. Selection of viable spermatozoa
via sperm filtration following 24 h cryostorage at 5 °C in
test-yolk buffer. Mol AndroI 1992; 4: 113-9.
- Kofinas GD, Zavos PM. Short term cryostorage technique
for human spermatozoa: its possible application in an
artificial insemination program. Infertility 1992; 15: 44-54.
- Lanzendorf SE, Holmgren WJ, Jeyendran RS. The effect of
egg yolk medium on human sperm binding in the hemizona
assay. Fertil Steril 1992;58: 547-550.
- Paulson RJ, Sauer MV, Francis MM, Macaso TM, Lobo
RA. A prospective controlled evaluation of TEST-yolk
buffer in the preparation of sperm for human in vitro
fertilization in suspected cases of male infertility. Fertil
SteriI1992;58: 551-555.
- Soffer Y, Golan A, Herman A, Pansky M, Caspi E, Ron-El
R. Prediction of in vitro fertilization outcome by sperm
penetration assay with TEST-yolk buffer preincubation.
Fertil Steril 1992; 58: 556-562.
- Garnzu R, Yavetz H, Lichtenberg D, Paz G, Homonnai ZT,
Yogev L. The effect ofegg yolk on the binding capacity of
human spermatozoa to zona pellucida. Fertil Steril 1994;
62: 1221-5.
- Katayama KP, Stehlik E, Jeyendran RS. In vitro
fertilization outcome: glass wool-filtered sperm versus
swim-up sperm. Fertil Steril 1989; 52: 670-2.
- World Health Organization. Laboratory manual for the
examination of human semen and sperm-cervical mucus
interaction. 3rd ed. Cambridge University Press, Cambridge,
1992.
- Zavos PM. Seminal parameters of ejaculates collected from
oligospermic and normospermic patients via masturbation
and at intercourse with the use of a Silastic seminal fluid
collection device. Fertil Steril 1985 Oct;44(4):517-20
- Zavos PM, Goodpasture Je. Clinical improvements of
specific seminal deficiencies via intercourse with a seminal
collection device versus masturbation. Fertil Steril 1989
Jan;51 (I): 190-3
- Jeyendran RN, Van der Ven, H.H., Perez-Pelaez, M.,
Crabo, B.G. & Zaneveld, L.J.D. Development of an assay
to assess the functional integrity of the human sperm
membrane and its relationship to other semen
characteristics. J Reprod Ferti 1984; 70: 219-228.
- Zavos PM, Correa JR, Zarmakoupis PN. Epididymal
spermatozoa: recovery and subsequent improvements of
mouse epididymal spermatozoa via the SperrnPrep™
filtration method. Tohoku J Exp Med 1995; 175: 101-9.
- SAS Institute, Inc. (1989) SAS User's Guide: Statistics,
Cary, Ne.
- Zavos PM. Principles of cryopreservation of human
spermatozoa: state-of-the-art. Infertility 1990; 13: 239-246.
- Zavos PM, Zarmakoupis-Zavos PN, Correa JR,
Abouabdalla M, Aslanis A. Variations in pregnancy rates
following intrauterine insemination among infertility
centers: can the inseminators make a difference? Middle
East Fertil Soc J 1997; 2: 24-29.
- Zavos PM, Barnes FL, Correa JR, Zarmakoupis-Zavos PN, Tesarik J. Methods
for the isolation and purification of
post-ejaculate human round spcrmatids for possible use in
intra cytoplasmic round spermatid injection. Middle East
Fertil Soc J 1997; 2:147-150.
- Zavos PM, Correa JR, Sofikitis N, Toda T, Zarmakoupis-Zavos
PN. The usefulness of pentoxifylline for the
recovery of human spermatozoa in assisted reproduction
technologies. Middle East Fertil Soc J 1996; I: 128-133.
- Correa JR and Zavos PM. Preparation of frozen-thawed
bovine spermatozoa via various sperm selection techniques
employed in assisted reproductive technologies.
Theriogenology 1996; 46: 413-420.
- Correa JR, Zarmakoupis-Zavos PN, Zavos PM.
Quantitative and qualitative characteristics of frozenthawed
bovine spermatozoa recovered via a conventional
and a standardized swim-up technique. Tohoku J Exp Med
1997; 181: 267-274.
- Zavos PM, Correa JR, Zarmakoupis-Zavos PN. Antisperm
antibody treatment mode: levels of antisperm antibodies
with Test-yolk buffer and filtration using the
SperrnPrep™ method. Fertil Steril 1998; 69(3): 517-21.
Now Only $69.75 shipping included

$69.75
Shipping Included*
If you would prefer to place your order over the phone,
or have additional questions,
you may call
us Monday-Friday 8:30am-5:00pm
Toll Free 1-800-998-4567
*Note: We can only ship to the lower 48 USA States only.

|